Latest Advances in Vebreltinib for High-Grade Glioma: Further Validation of Its Therapeutic Value

Top Stories

How Do EGFR×CD3 Bispecific Antibodies Activate T Cells to Kill Head and Neck Tumors? Mechanisms, Advantages, and Latest Clinical Progress

How High Is the Risk of Metastasis in Head and Neck Cancer? Understanding Common Metastatic Sites and Warning Signs

Latest Coverage

2026 Hypertension Guidelines Released: How Will Clinical Practice Change Around the World?
Explore the key updates in the 2026 hypertension guidelines, including stricter blood pressure targets, cardio-renal ...

How Can Head and Neck Cancers Be Detected Early? Warning Signs You Should Never Ignore
Discover the common symptoms, high-risk groups, diagnostic approaches, and treatment advances for head and neck cance...

Why Does HPV Increase the Risk of Oropharyngeal Cancer? Carcinogenic Mechanisms, Diagnosis, and the Latest Treatment Advances
In recent years, the incidence of HPV (Human Papillomavirus)-related oropharyngeal cancer (HPV-positive OPSCC) has co...

38 Innovative Drugs Approved in China in the First Half of 2026
According to public information released on the website of China’s National Medical Products Administration (NMPA), 3...

Can TCR-T Become the Next Breakthrough for Advanced Head and Neck Cancer?
Table of Contents

ADC Landscape in Head and Neck Cancer: Latest Advances in HER3, EGFR, B7-H3, and Other Emerging Targets
In recent years, antibody-drug conjugates (ADCs) have become one of the fastest-growing areas of innovation in oncolo...

In-Depth Analysis

Latest Advances in Vebreltinib for High-Grade Glioma: Further Validation of Its Therapeutic Value

How Do EGFR×CD3 Bispecific Antibodies Activate T Cells to Kill Head and Neck Tumors? Mechanisms, Advantages, and Latest Clinical Progress

How High Is the Risk of Metastasis in Head and Neck Cancer? Understanding Common Metastatic Sites and Warning Signs

2026 Hypertension Guidelines Released: How Will Clinical Practice Change Around the World?